"id","identifier","description","uuid:ID","name","instanceType","text","label"
"EligibilityCriterion_1","1","The study age criterion","3d1d3ef6-37f8-4969-bb7f-9b41e8a12abc","Age Criteria","EligibilityCriterion","Subjects shall be between [min_age] and [max_age]",""
"EligibilityCriterion_2","2","The study population criterion","e2556ac2-387b-491d-bb03-85ed9e3edb66","Pop Criteria","EligibilityCriterion","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)",""
"EligibilityCriterion_3","3","The study diagnosis criterion","06ba1984-8365-4c78-b47d-f112f27c71dd","Diag Criteria","EligibilityCriterion","[Activity1] score of 10 to 23",""
"EligibilityCriterion_4","9","The previous xanomeline TTS criterion","02cf1ba3-1309-41e4-9f4b-7887291d3617","Previous Criteria","EligibilityCriterion","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline.",""
